Disruption in Digital Health Innovation, and Why It's a Good Thing
Afternoon Panel at #PhRMA13 Offers Visionary New Tools for Patient, Provider, Manufacturer Success
04.11.13 | By Kaelan Hollon
The third and final panel today at #PhRMA13 tried on a new definition of what we consider "disruptive", and why we should like it. A disruptive technology or innovation improves not just what is known, but changes the modus operandi in completely unforeseen ways. Cloud computers, digital photography, downloadable music, mass-produced cars; these technologies didn't improve upon a specific line of thought, they renovated what had been considered possible. Todays panel, 'Innovation & Disruption and What We Can Learn', offered a platform for seven new thinkers to preview their notion of disruptive innovation as it applies to patients, shareholders and physicians, and the results were a healthcare innovator's version of The Matrix.
For manufacturers, the disruptive innovation technologies highlighted include cloud based clinical trial collaboration (GoBalto ), dynamic physician intelligence (Medikly ), algorithm-generated patient trends (Treato ), all of which enabled a manufacturer to connect with stakeholders in new ways, which can lead to better health outcomes.
The other end of disruptive technologies on the panel focused on how patients interact with their treatment regime and health care providers. Seamless sharing of medical records and patient information via a QR code scan (Humetrix ), chat-enabled patient adherence solutions (mHealthCoach ), integrated mobile solutions for patient financial planning (HealthExpense ) and scratch-off or SMS technology integrated into medicine labeling to enable consumers to verify the authenticity of a product instantly and assist in reducing counterfeiting (Sproxil ), are all representative of crucial entrepreneurs, disrupting all components of the pharmaceutical model with their thinking.
Plenty of other visionaries will be presenting tomorrow  for the patient-focused panel bright and early. Stay tuned for more from #PhRMA13!